scholarly journals Conversion to everolimus in pediatric heart transplant recipients is a safe treatment option with an impact on cardiac allograft vasculopathy and renal function

2020 ◽  
Author(s):  
Kathrin Grimm ◽  
Anja Lehner ◽  
Silvia Fernandez Rodriguez ◽  
Madeleine Orban ◽  
Marcus Fischer ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document